The nasal vaccine -- BBV154 -- had received Drugs Controller General of India's approval in November for restricted emergency use among adults...

The company's chief also said that the homegrown jab for lumpy skin disease in cattle, Lumpi-ProVacInd, is likely to be launched next month...

Since the launch of the anti-Covid vaccination drive, the company has so far provided 170 crore doses of Covishield to the govt...

Prakash Kumar Singh, director at Serum Institute of India had recently written a letter to Drugs Controller General of India for approval...

The DCGI had approved the SII's Covid vaccine for restricted use in emergency situations for adults on December 28, 2021...

The study underlines a wide variability among countries and the need for tailored communication strategies in addressing vaccine hesitancy...

State focus on vaccines, especially booster doses...

The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries...

Covovax was approved by the DCGI for a restricted emergency use in children aged seven to 11 years in June...

The nasal delivery system has been designed and developed to be cost-effective in low- and middle-income countries...